The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project

Cancer Causes and Control

Volumn 23, Issue 7, 2012, Pages 1193-1203

  Cleveland, Rebecca J ^a   North, Kari E ^b   Stevens, June ^b   Teitelbaum, Susan L ^c   Neugut, Alfred I ^d   Gammon, Marilie D ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Breast cancer; Diabetes; Survival

Indexed keywords

INSULIN; MEGLITINIDE; METFORMIN; SULFONYLUREA;

AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; SELF REPORT;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COMORBIDITY; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MIDDLE AGED; NEW YORK; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 84862493532     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-9989-7     Document Type: Article

References (55)

1. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053 (Pubitemid 38579764)
2. Wild S, Roglic G, Green A, Sicree R, King H (2011) Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta
3. Carmichael AR (2006) Obesity as a risk factor for development and poor prognosis of breast cancer. BJOG 113:1160-1166
4. Cleveland RJ, Eng SM, Abrahamson PE et al (2007) Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiol Biomarkers Prev 16:1803-1811 (Pubitemid 47450510)
5. Loi S, Milne RL, Friedlander ML et al (2005) Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 14:1686-1691 (Pubitemid 40995080)
6. Vona-Davis L, Howard-McNatt M, Rose DP (2007) Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev 8:395-408 (Pubitemid 47283945)
7. Kaaks R (1996) Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 7:605-625
8. Lawlor DA, Smith GD, Ebrahim S (2004) Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study. Cancer Causes Control 15:267-275 (Pubitemid 38988035)
9. Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856-862 (Pubitemid 47106217)
10. van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR (2007) Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. International journal of cancer. Journal International du Cancer 120:1986-1992 (Pubitemid 46418378)
11. Srokowski TP, Fang S, Hortobagyi GN, Giordano SH (2009) Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27:2170-2176
12. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2008) The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat 109:389-395 (Pubitemid 351644852)
13. Fleming ST, Rastogi A, Dmitrienko A, Johnson KD (1999) A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer. Med Care 37:601-614
14. Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42-51 (Pubitemid 34032594)
15. Bodmer M, Meier C, Krahenbuhl S, Jick SS, Meier CR (2010) Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care 33:1304-1308
16. Bowker SL, Majumdar SR, Veugelers P, Johnson JA (2006) Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 29:254-258 (Pubitemid 44106500)
17. Monami M, Lamanna C, Balzi D, Marchionni N, Mannucci E (2009) Sulphonylureas and cancer: a case-control study. Acta Diabetol 46:279-284
18. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2006) Diabetes mellitus and breast cancer: a retrospective population- based cohort study. Breast Cancer Res Treat 98:349-356 (Pubitemid 44195606)
19. Sanderson M, Peltz G, Perez A et al (2010) Diabetes, physical activity and breast cancer among Hispanic women. Cancer Epidemiol 34:556-561
20. Gammon MD, Neugut AI, Santella RM et al (2002) The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat 74:235-254 (Pubitemid 34848352)
21. Waksberg J (1978) Sampling methods for random digit dialing. J Am Statistic Assoc 73:40-46
22. Michels KB, Solomon CG, Hu FB et al (2003) Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 26:1752-1758 (Pubitemid 36929115)
23. Sellers TA, Jensen LE, Vierkant RA et al (2007) Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study. Cancer causes & Control: CCC 18:505-515 (Pubitemid 46684825)
24. Hosmer DW, Lemeshow S (2000) Applied logistic regression. Wiley, New York
25. Allison P (1995) Survival analysis using SAS: a practical guide. SAS Publishing, Cary
26. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285:885-892 (Pubitemid 32171549)
27. Schrauder MG, Fasching PA, Haberle L et al (2011) Diabetes and prognosis in a breast cancer cohort. J Cancer Res Clin Oncol 137:975-983
28. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160-1167 (Pubitemid 38747263)
29. Verlato G, Zoppini G, Bonora E, Muggeo M (2003) Mortality from site-specific malignancies in type 2 diabetic patients from Verona. Diabetes Care 26:1047-1051 (Pubitemid 36929246)
30. Du W, Simon MS (2005) Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res Treat 91:243-248 (Pubitemid 40896570)
31. Lipscombe LL, Hux JE, Booth GL (2005) Reduced screening mammography among women with diabetes. Arch Intern Med 165:2090-2095 (Pubitemid 41434583)
32. Seshasai SR, Kaptoge S, Thompson A et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829-841
33. Papa V, Belfiore A (1996) Insulin receptors in breast cancer: biological and clinical role. J Endocrinol Invest 19:324-333 (Pubitemid 126450113)
34. Hanley AJ, Festa A, D'Agostino RB Jr et al (2004) Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes 53:1773-1781 (Pubitemid 38857035)
35. Xu H, Barnes GT, Yang Q et al (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830 (Pubitemid 38063705)
36. Wilson C (2011) Diabetes: long-term use of insulin glargine might increase the risk of breast cancer. Nat Rev Endocrinol
37. Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K (2009) Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 69:7507-7511
38. Landman GW, Kleefstra N, van Hateren KJ, Groenier KH, Gans RO, Bilo HJ (2010) Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care 33:322-326
39. Odegard PS, Capoccia K (2007) Medication taking and diabetes: a systematic review of the literature. Diabetes Educ. 33:1014-1029 discussion 30-1
40. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2006) Increased prevalence of prior breast cancer in women with newly diagnosed diabetes. Breast Cancer Res Treat 98:303-309 (Pubitemid 44195600)
41. Decensi A, Puntoni M, Goodwin P et al (2010) Metformin and cancer risk in diabetic patients: a systematic review and metaanalysis. Cancer Prev Res (Phila) 3:1451-1461
42. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569-578 (Pubitemid 351232031)
43. Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606-616 (Pubitemid 34498648)
44. Simard J, Gingras S (2001) Crucial role of cytokines in sex steroid formation in normal and tumoral tissues. Mol Cell Endocrinol 171:25-40 (Pubitemid 32101368)
45. Eng SM, Gammon MD, Terry MB et al (2005) Body size changes in relation to postmenopausal breast cancer among women on Long Island. New York. American Journal of Epidemiology 162:229-237 (Pubitemid 41373527)
46. Huang Z, Hankinson SE, Colditz GA et al (1997) Dual effects of weight and weight gain on breast cancer risk. JAMA 278:1407-1411 (Pubitemid 27475968)
47. Jurgens RW Jr, Downey LJ, Abernethy WD, Cutler NR, Conrad J (1992) A comparison of circulating hormone levels in postmenopausal women receiving hormone replacement therapy. Am J Obstet Gynecol 167:459-460
48. Barclay AW, Petocz P, McMillan-Price J et al (2008) Glycemic index, glycemic load, and chronic disease risk - a meta-analysis of observational studies. Am J Clin Nutr 87:627-637 (Pubitemid 351364544)
49. George SM, Mayne ST, Leitzmann MF et al (2009) Dietary glycemic index, glycemic load, and risk of cancer: a prospective cohort study. Am J Epidemiol 169:462-472
50. Kabat GC, Shikany JM, Beresford SA et al (2008) Dietary carbohydrate, glycemic index, and glycemic load in relation to colorectal cancer risk in the Women's Health Initiative. Cancer Causes Control 19:1291-1298
51. Link CL, McKinlay JB (2009) Disparities in the prevalence of diabetes: is it race/ethnicity or socioeconomic status? Results from the Boston Area Community Health (BACH) survey. Ethn Dis 19:288-292
52. Signorello LB, Schlundt DG, Cohen SS et al (2007) Comparing diabetes prevalence between African Americans and Whites of similar socioeconomic status. Am J Public Health 97:2260-2267 (Pubitemid 351194707)
53. Okosun IS, Liao Y, Rotimi CN, Prewitt TE, Cooper RS (2000) Abdominal adiposity and clustering of multiple metabolic syndrome in White. Black and Hispanic americans. Ann Epidemiol 10:263-270 (Pubitemid 30609607)
54. Berman DM, Rodrigues LM, Nicklas BJ, Ryan AS, Dennis KE, Goldberg AP (2001) Racial disparities in metabolism, central obesity, and sex hormone-binding globulin in postmenopausal women. J Clin Endocrinol Metab 86:97-103 (Pubitemid 32109781)
55. Berman DM, Rodrigues LM, Nicklas BJ, Ryan AS, Dennis KE, Goldberg AP (2011) Early Release of Selected Estimates Based on Data From the 2010 National Health Interview Survey. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta